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Abstract
Objectives: Migraine is a suggested risk factor for aneurysmal subarachnoid hemor-
rhage	(aSAH).	An	 increased	risk	of	aSAH	in	migraineurs	may	be	explained	by	an	 in-




Materials and Methods: Patients	with	UIA	were	recruited	from	two	university	hospi-
tals.	Data	on	patients	with	TIA/stroke	were	retrieved	from	a	previous	study.	Partners	
of	patients	with	UIA	or	TIA/stroke	were	 included	as	controls.	Migraine	history	was	












with	 controls	 and	 comparable	 with	 the	 prevalence	 in	 patients	 with	 TIA	 or	 stroke.	
Further studies are needed to confirm our findings and to investigate the underlying 
pathophysiology.
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1  | INTRODUCTION








ysis for hemorrhagic stroke subtype was not possible because of the 
unavailability	of	separate	data	on	aSAH	and	intracerebral	hemorrhage.	
One	case–control	study	with	only	aSAH	patients	found	no	difference	
in	 self-	reported	 migraine	 prevalence	 (Carter,	 Anderson,	 Jamrozik,	
Hankey,	&	Anderson,	2005).	The	large	prospective	of	Women’s	Health	
Study,	however,	suggested	an	increased	risk	of	aSAH	for	women	with	
migraine after long- term follow- up although this was not statistically 
significant	 (Kurth,	 Kase,	 Schurks,	Tzourio,	 &	 Buring,	 2010).	Another	
large prospective population- based cohort study from Taiwan found 






prevalence	of	 aneurysms,	 a	 higher	 risk	 of	 rupture	or	 both.	 Possibly,	
vascular mechanisms involved in the pathophysiology of migraine or 





out	 aura	 in	 patients	 with	 unruptured	 intracranial	 aneurysms	 (UIA)	
compared	with	patients	with	TIA/Stroke	and	with	controls.







older than 18 years of age were included who had one or more un-






for	 their	UIA	were	 also	 excluded,	 as	 headache	 complaints	 resulting	
from	 the	 aSAH	 or	 from	 treatment	may	 be	 confused	with	migraine	
complaints,	and	cognitive	impairments	resulting	from	the	aSAH	may	


















reviewed the research protocol and granted a waiver for the project.
2.2 | Migraine interview
All	eligible	patients	with	UIA	received	an	invitation	letter	announcing	
an interview by telephone. Patients who did not want to be contacted 
had the possibility to return a statement that they did not want to 
participate.	The	interviewer	was	a	medical	student	(EHW),	who	was	
trained to perform a migraine interview by a migraine research physi-
cian	 (NP)	 from	 the	 LUMC.	Migraine	history	was	 first	 assessed	with	
the short Migraine Screener for Stroke (MISS) questionnaire (van der 
Willik	et	al.,	2017).	The	MISS	contains	five	questions	about	the	self-	
diagnosis	 of	migraine,	 the	diagnosis	 of	migraine	by	 a	physician,	 the	
frequency	of	attacks,	as	well	as	associated	symptoms	such	as	vom-
iting,	 photo-	 and	 phonophobia,	 and	 concomitant	 visual	 symptoms.	
The	MISS	has	a	high	negative	predictive	value	 (0.99),	and	a	reason-
able	positive	predictive	value	 (0.71).	A	more	detailed	 interview	was	
conducted when results of the MISS questionnaire were suggestive 
of migraine (a positive answer to at least one of the questions). In 
this	 interview,	 the	migraine	diagnosis	was	 verified	 according	 to	 the	
criteria	of	the	International	Classification	of	Headache	Disorders,	sec-
ond	 edition	 (ICHD-	2)	 by	 the	 International	Headache	 Society	which	
are	comparable	with	the	recent	updated	ICHD-	III	criteria	(Headache	
Classification	 Committee	 of	 the	 International	 Headache	 Society,	
2013).	All	 interviews	in	patients	and	controls	were	discussed	with	a	




Migraine diagnoses were divided into two subtypes: (1) migraine 
with aura; and (2) migraine without aura. Patients who reported both 
migraine with and without aura were included in the migraine with 
aura group. Patients with aura without (migrainous) headache were 
considered to have migraine with aura.
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2.3 | Assessment of risk factors
Possible	 vascular	 risk	 factors	 for	migraine,	 stroke	 and	UIA,	 such	 as	
smoking	 and	 hypertension,	 were	 retrieved	 from	 medical	 records.	
The presence of these risk factors was also asked during the tele-
phone	interview.	Smokers	were	categorized	into	three	groups:	never	
smoked,	 former	 smokers,	 and	 current	 smokers.	 Hypertension	 was	




of	migraine	 history	with	 95%	 confidence	 intervals	 (CI)	 between	 (1)	
patients	with	an	UIA	and	controls;	and	(2)	patients	with	an	UIA	and	
patients	with	a	history	of	TIA	or	stroke.	In	multivariable	analyses,	ad-
justments	were	made	 for	 age,	 sex,	 smoking	 and	 hypertension.	ORs	






who were eligible to participate in the study (Figure 1). Reasons 
for	 exclusion	were:	 decline	 to	participate	 (n	=	36),	 lost	 to	 follow	up	
(n	=	30),	history	of	SAH	(n	=	25),	and	headache	as	reason	of	imaging	
(n	=	17).	All	patients	with	a	history	of	TIA/stroke	from	the	MISS	vali-




and clinical characteristics of the included patients and controls are 










Results of the univariable and multivariable analyses are shown in 
Table	2.	In	the	univariable	analysis,	OR	for	migraine	in	UIA	patient	ver-
sus	controls	was	1.9	(95%	CI	1.1–3.3).	The	strength	of	the	relationship	
did not differ between patients with migraine without aura (OR 1.8; 
95%	CI	0.9–3.5),	and	patients	with	migraine	with	aura	(OR	1.7;	95%	
CI	0.7–4.2).	After	adjustments	 for	age,	sex,	hypertension	and	smok-






Our results suggest that migraine prevalence might be higher in 
patients	 with	 UIA	 than	 in	 controls.	 The	 prevalence	 was	 compara-
ble	with	 that	 in	 the	 group	 of	 patients	with	 TIA	 or	 ischemic	 stroke,	
who are known from previous studies to have an increased migraine 
prevalence.
In	another	retrospective	study,	an	increased	prevalence	of	migraine	
without aura was found in patients with an intracranial aneurysm in 
F IGURE  1 Flowchart	of	UIA	patients.	UIA,	unruptured	intracranial	
aneurysm;	aSAH,	aneurysmal	subarachnoid	hemorrhage.	*Loss	to	
follow- up mostly occurred because patients moved to another city or 
changed their phone number
TABLE  1 Baseline characteristics of the study population





Mean	age,	year	(SD) 64.2 (10.1) 67.4 (12.3) 63.4	(9.8)
Men	(%) 64 (37.2) 117	(52.9) 72	(43.9)
Migraine	history	(%) 42 (24.4) 49	(22.2) 24 (14.6)
MO	(%) 28 (16.3) 28 (12.7) 16	(9.8)





Former smokers 90	(52.3) 92	(41.6) 76 (46.3)
Current smokers 46 (26.7) 35	(15.8) 27	(16.5)
Never smoked 36	(20.9) 90	(40.7) 61 (37.2)
Hypertension	(%) 95	(55.2) 134 (60.6) 57	(34.8)
UIA,	unruptured	 intracranial	aneurysm;	MO,	migraine	without	aura;	MA,	
migraine	with	aura;	aSAH,	aneurysmal	subarachnoid	hemorrhage.
aData of one person missing.
bData	of	four	TIA/Stroke	patients	unavailable.
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Our	 study	 revealed	 a	 lower	 migraine	 prevalence	 in	 the	 UIA	 group,	
which	may	be	explained	by	difference	in	study	population	since	aSAH	
patients	were	excluded	from	our	study.	A	history	of	SAH	may	lead	to	
a recall bias by overestimating or misinterpreting previous headache 
complaints	by	patients.	In	addition,	cognitive	impairment	after	aSAH	
may have had an influence on the interviews in these patients.
Of	all	patients	with	UIA	who	were	included	in	our	study,	110	were	
derived	from	another	study	on	risk	factors	for	UIA	(Vlak	et	al.,	2013).	
This other study investigated a range of possible risk factors by send-
ing	out	questionnaires	by	mail,	which	included	only	one	question	on	
migraine history. To achieve a more reliable and uniform assessment 
of	migraine	history,	we	decided	to	approach	all	patients	again	for	the	
present study by telephone with a short validated migraine screener 
followed	by	an	extensive	 interview.	With	our	validated	migraine	as-
sessment we found a remarkably higher prevalence of migraine in the 
overlapping	group	of	110	UIA	patients	(24.4%	in	our	study	vs.	7%	in	
the	previous	study;	Vlak	et	al.,	2013).	This	difference	may	be	due	to	
an underestimation of migraine prevalence by only asking whether pa-
tients had ever been diagnosed with migraine. Many migraine patients 
may	never	have	consulted	a	physician	for	their	headache	complaints,	
and	have,	therefore,	never	been	diagnosed	with	migraine.
Some	 limitations	 of	 our	 study	 should	 be	 acknowledged.	 First,	
selection	 bias	may	 have	 occurred,	 as	 some	 patients	with	 UIA	were	
diagnosed after having an ischemic stroke. Because migraine is an es-
tablished	risk	factor	for	an	ischemic	stroke,	this	could	have	influenced	




ogists	 in	 our	 department	 are	 specialized	 in	 both	vascular	 neurology	
and	 migraine,	 we	 cannot	 completely	 rule	 out	 that	 some	 migraine	
auras	might	have	been	misdiagnosed	as	TIA.	Second,	all	participants	
were	informed	that	our	study	was	about	migraine.	Therefore,	patients	
with migraine complaints may have been more likely to respond and 
participate	 in	 our	 study	 than	 patients	 without	 migraine.	 However,	
as	patient	and	control	groups	were	all	approached	 in	the	same	way,	
we consider it unlikely that this selection bias has greatly influenced 
our	results.	Third,	the	mean	age	of	all	participants	was	approximately	
65	years,	and	as	the	peak	prevalence	of	migraine	is	around	35	years,	
some of the migraine diagnoses were based on complaints occurring 
in	the	past	(Ferrari,	1998).	Although	the	time	between	interview	and	
migraine	complaints	is	similar	on	an	average	for	all	groups,	the	patient	
groups may have been reflecting more intensely on previous health 
problems	since	their	diagnosis,	causing	recall	bias.	Fourth,	because	we	
performed	a	 case–control	 study	we	 could	not	 infer	 any	 causal	 rela-
tions.	 Ideally,	a	cohort	study	should	be	performed,	but	such	a	study	
is	difficult	to	carry	out	in	practice,	because	it	requires	large	groups	of	
persons with and without migraine with long- term brain imaging fol-









There are also strong points of our study. We had access to a large 
number	of	patients	with	UIA,	and	were	not	only	able	to	compare	them	
with	controls	but	also	with	patients	with	a	history	of	TIA	or	stroke.	We	









from a perivascular sensory nerve terminal around the terminals or a 
local	stimulator	of	the	dura	mater,	may	increase	the	sensitization	in	the	
cranial	nervous	system	(Lebedeva	et	al.,	2013).	A	previous	study	found	
no difference in the prevalence of migraine without aura between 

















Migraine total 1.9	(1.1–3.3) 1.1	(0.7–1.8) 1.7	(1.0–3.1) 0.9	(0.5–1.5)
MO 1.8	(0.9–3.5) 1.3	(0.8–2.4) 1.7	(0.8–3.4) 1.3	(0.7–2.4)
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Another	 hypothesis	 is	 that	 migraine	 may	 influence	 the	 devel-









studies	showed	that	a	SNP	 in	 the	LRP1	protein,	 that	plays	a	 role	 in	
vascular	wall	integrity,	increases	the	risk	of	both	migraine	without	aura	
and	 abdominal	 aneurysms	 (Bown	et	al.,	 2011;	 Freilinger,	Anttila,	De	
Vries,	&	Malik,	2013).	The	association	between	LRP1	and	intracranial	
aneurysms	 has	 to	 our	 knowledge	 not	 been	 studied	yet.	Apart	 from	
the	hypothesized	direct	causal	associations,	 it	 is	 likely	that	there	are	
common cardiovascular risk factors associated with both migraine 
and	 UIA,	 such	 as	 hypertension	 and	 smoking	 although	we	 adjusted	
for	these	factors	in	our	analyses	(Scher	et	al.,	2005;	Vlak	et	al.,	2013).	
More studies are needed to confirm our findings and to further investi-
gate the underlying pathophysiology between the possible association 
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